Search for: "BAR'S PRODUCTS INC" Results 281 - 300 of 5,730
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Sep 2020, 9:09 am by Rebecca Tushnet
American Honda Motor Co., Inc., 666 F.3d 581 (9th Cir. 2012), on nationwide classes? [read post]
19 Feb 2014, 5:52 pm
Inc. at *3.HoldingWe conclude that the foreseeability of an equivalent at the time of patenting is not a bar to a finding of infringement under the doctrine of equivalents.Id. at *5. [read post]
28 Jun 2017, 11:58 am by Lorraine Fleck
  June 13, 2014 Equustek sought and was granted an interlocutory injunction by the BCSC, barring Google from displaying any portion of the Datalink websites on any of Google search results worldwide. [read post]
20 Mar 2023, 9:10 am by Rebecca Tushnet
 IP at the Supreme Court Series: Jack Daniel’s Properties, Inc. v. [read post]
6 Apr 2010, 2:59 am
Chino, CA-based Golden Pacific Foods, Inc. has recalled its Marco Polo Brand Shrimp Snacks sold as Original, Onion & Garlic Flavored, and Bar-B-Que Flavored, because they may contain undeclared milk and soy.People who have allergies to milk and soy run the risk of serious or life-threatening reaction if they consume these products.The following Marco Polo Brand items and product codes with expiration dates of 08-13-10 or earlier are affected by the recall were sold… [read post]
15 Mar 2013, 8:54 am
  If the application for such a patent is not filed within one year of the public offering or sale of the products, the statutory bar under 35 U.S.C. [read post]
16 Apr 2018, 10:01 am by Andrew Levad and Jason Gordon
The Federal Trade Commission (“FTC”) recently reached an agreement with New York-based Telomerase Activation Sciences, Inc. and its CEO Noel Patton (collectively, “TA Sciences”), barring TA Sciences from making false or unsubstantiated claims regarding the efficacy and health benefits of two of TA Sciences’ products. [read post]
16 Apr 2018, 10:01 am by Andrew Levad and Jason Gordon
The Federal Trade Commission (“FTC”) recently reached an agreement with New York-based Telomerase Activation Sciences, Inc. and its CEO Noel Patton (collectively, “TA Sciences”), barring TA Sciences from making false or unsubstantiated claims regarding the efficacy and health benefits of two of TA Sciences’ products. [read post]